Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Unknown × Sitagliptin Phosphate × Clear all

Phase

Phase 4 1 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1

Interventions

Docetaxel 18 Cisplatin 17 Capecitabine 17 Oxaliplatin 14 Drug Therapy 14 Cyclophosphamide 14 Fluorouracil 12 Radiotherapy 11 Paclitaxel 9 apatinib 8 Epirubicin 8 Doxorubicin 8 Decitabine 8 Gemcitabine 7 Carboplatin 7 sintilimab 6 Methotrexate 6 Busulfan 6 camrelizumab 5 anlotinib 5 XELOX 5 Pemetrexed 5 Neoadjuvant Therapy 5 Leucovorin 5 Etoposide 5 Dexamethasone 5 lenvatinib 4 Surgical Procedures, Operative 4 Sorafenib 4 Radiosurgery 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05972928 2023-08-02

Effect of Sitagliptin on Polycystic Ovarian Syndrome Patients

Beni-Suef University

Phase 2/3 Unknown

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡